Compare TechnipFMC plc Ordinary Share (FTI) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TechnipFMC plc Ordinary Share vs Halozyme Therapeutics Inc. Common Stock — how do they compare? TechnipFMC plc Ordinary Share trades at $70.22 (market cap $27.31B), while Halozyme Therapeutics Inc. Common Stock trades at $111.11 (market cap $12.58B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 2.2× Halozyme Therapeutics Inc. Common Stock's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FTI | HALO | |
|---|---|---|
Market Cap | $27.31B | $12.58B |
Volume | 2,496,410 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $80.08 | $115.22 |
52-Week Low | $35.57 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $27.56B | $14.49B |
Dividend Yield | 0.29% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TechnipFMC plc Ordinary Share
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
